Halper Sadeh LLC Investigates ESI, CRNX, SOLS Deals for Shareholder Fairness

GlobeNewswire··Read original
2▲1 ▼0Impact / 5
Summary · why it matters

Halper Sadeh LLC, an investor rights law firm, is investigating whether Element Solutions Inc, Crinetics Pharmaceuticals Inc, and Solstice Advanced Materials Inc are obtaining fair deals for their shareholders. The investigation concerns Element Solutions' sale to Solstice Advanced Materials for $10.00 in cash and 0.500 shares of Solstice common stock per Element share, with Element shareholders expected to own approximately 44% of the combined company upon closing. It also covers Crinetics Pharmaceuticals' sale to Vertex Pharmaceuticals for $85.00 per share in cash, and Solstice Advanced Materials' merger with Element Solutions. The firm may seek increased consideration, additional disclosures, or other relief on behalf of shareholders.

Impact on assets 3

Biotech & Genomic Medicine▲ · 1 stocks
Crinetics Pharmaceuticals Inc
CRNX
▲ PositiveCapitalrelevance

Crinetics Pharmaceuticals is being acquired by Vertex Pharmaceuticals for $85.00 per share in cash, a premium that benefits shareholders.

Semiconductors▲ · 1 stocks
Element Solutions Inc
ESI
± MixedCapitalrelevance

Element Solutions is being acquired by Solstice Advanced Materials; the deal's fairness is under investigation, creating uncertainty for shareholders.

Critical Materials & Supply Chain▲ · 1 stocks
© 2026 MarketIVNews